Synopsis : A recent drug safety alert from the Central Drug Standard Control Organisation has flagged Telma AM, a widely used hypertension medication by Glenmark Pharmaceuticals, as "Not of Standard Quality" after laboratory tests confirmed it failed to meet Indian Pharmacopoeia standards. The drug was among 145 medicines identified as substandard in January 2025, leading to quality control concerns in pharmaceutical industry.